James Arthos

Title: James Arthos: Innovator in HIV Therapeutics

Introduction

James Arthos is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of HIV therapeutics, holding a total of 2 patents. His work focuses on developing therapeutic agents that can effectively combat the human immunodeficiency virus (HIV).

Latest Patents

Arthos's latest patents include innovations related to internal deletion mutants of soluble T4(CD4). This invention provides a therapeutic agent capable of specifically forming a complex with the HIV envelope glycoprotein. The polypeptide involved in this invention has specific amino acid sequences that are crucial for its function. Additionally, the invention outlines methods for treating subjects infected with HIV using a pharmaceutical composition that includes the therapeutic agent. Another significant patent involves derivatives of soluble T-4, which also aims to create a therapeutic agent that interacts with the HIV envelope glycoprotein. This patent similarly details methods for treating HIV-infected subjects.

Career Highlights

Throughout his career, James Arthos has worked with prestigious institutions, including Columbia University and SmithKline Beecham Corporation. His experience in these organizations has contributed to his expertise in the field of HIV research and therapeutics.

Collaborations

Arthos has collaborated with notable figures in the scientific community, including Paul J. Maddon and Richard Axel. These collaborations have likely enriched his research and contributed to the advancements in his patented technologies.

Conclusion

James Arthos is a prominent inventor whose work in HIV therapeutics has the potential to make a significant impact on treatment options for infected individuals. His innovative patents and collaborations highlight his dedication to advancing medical science.